@misc{indiciae315180571de9,
  title = {Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.},
  author = {Linong Ji and Malik Benamar and Viswanathan Mohan and Laura Pletsch-Borba and Francesca Porcellati and Ni Wang and Hirotaka Watada and Rosangela R Rea},
  year = {2026},
  doi = {10.1016/s2213-8587(26)00136-1},
  url = {https://pubmed.ncbi.nlm.nih.gov/42594928/},
  note = {Source identifier: 42594928}
}